Table 1.
Authors | Percentage of postive nodes (%) | Nodes removed (mean) | Survival benefit | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Not specified | Standard | Extended | Super–extended | Standard | Extended | Super–Extended | No LND | Limited LND | Standard LND | Extended LND | Super–extended LND | |
Tarin et al. (9) | 19 | |||||||||||
Moschini et al. (3) | 26.3 | 4.6 | 3.2 | 20 | ||||||||
Li et at. (14) | 14.6 | |||||||||||
Herr et al. (16) | 21 | 33%* | 46%* | 60%* | ||||||||
Dhar et al. (18) | 13 | 26 | 1 | 2 | 7%** | 35%** | ||||||
Zehnder et al. (19) | 28 | 35 | 22 | 38 | 54*** | 50*** |
5 years survival rate.
5 years recurrence free survival.
5 years overall survival.